Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_3

25%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (25.0%)

Phase 31 (25.0%)

N/A2 (50.0%)

Trials by Status

completed375%

withdrawn125%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_2

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

NCT03268941

completednot_applicable

To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis

NCT02528760

withdrawnnot_applicable

Rescue Emetic Therapy for Children Having Elective Surgery

NCT01067677

completedphase_3

Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants

NCT00131248

Clinical Trials (4)

Showing 4 of 4 trials

NCT03268941Phase 2

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

Completed

NCT02528760Not Applicable

To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis

Completed

NCT01067677Not Applicable

Rescue Emetic Therapy for Children Having Elective Surgery

Withdrawn

NCT00131248Phase 3

Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4